Dunwan Zhu
- Biomaterials top 0.5%
- Nanoparticle-Based Drug Delivery 29
- Molecular Medicine top 2%
- Hydrogels: synthesis, properties, applications 8
- Pharmaceutical Science top 1%
- Biomedical Engineering top 1%
- Nanoplatforms for cancer theranostics 46
- Immunology top 5%
- Immunotherapy and Immune Responses 17
- Immune cells in cancer 9
-
- RNA Interference and Gene Delivery 29
- Advanced biosensing and bioanalysis techniques 11
-
- Photodynamic Therapy Research Studies 9
- Journals
- Nature Communications (1 paper)SHILAP Revista de lepidopterología (1 paper)Nano Letters (3 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Dunwan Zhu
101 papers receiving 3.3k citations
Peers
Comparison fields: 5 of 122
- Biomaterials 1.4k
- Molecular Medicine 287
- Pharmaceutical Science 277
- Biomedical Engineering 1.8k
- Immunology 615
Countries citing papers authored by Dunwan Zhu
This map shows the geographic impact of Dunwan Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dunwan Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dunwan Zhu more than expected).
Fields of papers citing papers by Dunwan Zhu
This network shows the impact of papers produced by Dunwan Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dunwan Zhu. The network helps show where Dunwan Zhu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Dunwan Zhu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 4 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 6 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 17 | |
| 7 | 2024 | 7 | |
| 8 | 2023 | 97 | |
| 9 | 2021 | 107 | |
| 10 | 2019 | 86 | |
| 11 | 2019 | 94 | |
| 12 | 2018 | 53 | |
| 13 | 2018 | 25 | |
| 14 | 2017 | 81 | |
| 15 | 2016 | 3 | |
| 16 | 2014 | 28 | |
| 17 | 2013 | 21 | |
| 18 | 2011 | 24 | |
| 19 | 2010 | 14 | |
| 20 | 2006 | 3 |
About Dunwan Zhu
Dunwan Zhu is a scholar working on Biomaterials, Molecular Medicine and Pharmaceutical Science, having authored 106 papers that have together received 3.4k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (46 papers), RNA Interference and Gene Delivery (29 papers), Nanoparticle-Based Drug Delivery (29 papers), Immunotherapy and Immune Responses (17 papers), Advanced biosensing and bioanalysis techniques (11 papers), Photodynamic Therapy Research Studies (9 papers), Immune cells in cancer (9 papers) and Hydrogels: synthesis, properties, applications (8 papers). The work is most often cited by research in Biomaterials (1.4k citations), Molecular Medicine (287 citations) and Pharmaceutical Science (277 citations). Dunwan Zhu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Lin Mei, Linhua Zhang, Xigang Leng, Deling Kong, Xia Dong, Chenlu Huang, Hongfan Sun, Feng Lv, Linhua Zhang and Yu Qin. Their work appears in journals such as Nature Communications, SHILAP Revista de lepidopterología and Nano Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.